Deep Apple Therapeutics, announced a research collaboration and exclusive worldwide license agreement with Novo Nordisk to discover, develop and commercialize oral small molecule therapies...
Gensaic, Inc., a biotechnology company that combines AI-powered protein design with biological insights to discover ligands for tissue-selective intracellular delivery, announced a license and...
NanoVation Therapeutics, a platform company developing innovative technologies to overcome the barriers of nucleic acid delivery, announced a multi-year partnership with Novo Nordisk to...
Novo Nordisk announced that the company has received the results from the Volume Based Procurement (VBP) tender for insulin in China. The Chinese National...
